# Aripiprazole Once-monthly in Patients With Schizophrenia

> **NCT01959035** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 88 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole once-monthly

## Key facts

- **NCT ID:** NCT01959035
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2017-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01959035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01959035, "Aripiprazole Once-monthly in Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01959035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*